GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Net Income Including Noncontrolling Interests

4basebio (XTER:88Q) Net Income Including Noncontrolling Interests : €-7.27 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

4basebio's Net Income Including Noncontrolling Interests for the six months ended in Jun. 2023 was €-4.14 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 was €-7.27 Mil.

4basebio Net Income Including Noncontrolling Interests Historical Data

The historical data trend for 4basebio's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Net Income Including Noncontrolling Interests Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Net Income Including Noncontrolling Interests
-0.50 -0.79 -3.81 -5.92

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial -1.92 -1.87 -2.83 -3.13 -4.14

4basebio Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-7.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4basebio Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of 4basebio's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
LSE:ETX LSE:AREC LSE:OBD LSE:DEST LSE:SBTX LSE:SAR LSE:FUM LSE:TRX LSE:REDX LSE:C4XD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
4BB:UK
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
Website
https://www.4basebio.com
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines